These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7949184)

  • 1. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells.
    Slapak CA; Mizunuma N; Kufe DW
    Blood; 1994 Nov; 84(9):3113-21. PubMed ID: 7949184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
    Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
    Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
    Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY
    Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
    Slapak CA; Lecerf JM; Daniel JC; Levy SB
    J Biol Chem; 1992 May; 267(15):10638-44. PubMed ID: 1350280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
    Cleary I; Doherty G; Moran E; Clynes M
    Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
    Germann UA; Ford PJ; Shlyakhter D; Mason VS; Harding MW
    Anticancer Drugs; 1997 Feb; 8(2):141-55. PubMed ID: 9073310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of daunorubicin-resistant AML-2 sublines.
    Choi CH; Ling V
    Mol Cells; 1997 Apr; 7(2):170-7. PubMed ID: 9163728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.
    Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M
    Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
    Slapak CA; Martell RL; Terashima M; Levy SB
    Biochem Pharmacol; 1996 Nov; 52(10):1569-76. PubMed ID: 8937472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.